HT
PLRX icon

Headlands Technologies’s Pliant Therapeutics PLRX Stock Holding History

Headlands Technologies’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.4K Buy
+33,688
New +$41K ﹤0.01% 683

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Headlands Technologies's PLRX Position: Q2 2026 in Review

Headlands Technologies opened a new position in Pliant Therapeutics (PLRX) in Q2 2026: 33,688 shares worth $38.4K. The stake represents ﹤0.01% of the portfolio and ranks #683 among its holdings.

86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Headlands Technologies held 33,688 shares of Pliant Therapeutics worth $38.4K as of Q2 2026.
  • Pliant Therapeutics was a new Headlands Technologies position in Q2 2026.
  • Pliant Therapeutics made up ﹤0.01% of Headlands Technologies's portfolio in Q2 2026, its #683 holding.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.